Company Filing History:
Years Active: 2016
Title: Innovations by Hideki Tomoike in Hypertension and Diabetes Treatment
Introduction
Hideki Tomoike is a notable inventor based in Tokyo, Japan. He has made significant contributions to the field of medicine, particularly in the treatment of hypertension and diabetes mellitus. His innovative approach combines SGLT 2 inhibitors with antihypertensive drugs, showcasing a unique method to address complex health issues.
Latest Patents
Hideki Tomoike holds 1 patent for his invention titled "Combinations of SGLT 2 inhibitors and antihypertensive drugs." This patent describes medicaments that utilize a combination of SGLT 2 inhibitors and antihypertensive drugs, which are beneficial in treating diseases related to hypertension and diabetes mellitus. The invention demonstrates superior hypotensive action that cannot be achieved with single antihypertensive drugs. It effectively addresses the challenges associated with using multiple antihypertensive medications to lower blood pressure. Additionally, the invention shows significant therapeutic efficacy in managing diabetes mellitus and its complications, particularly diabetic nephropathy. It also proves useful for treating diseases involving reduced renal function.
Career Highlights
Hideki Tomoike is associated with Taisho Pharmaceutical Co., Ltd., where he continues to innovate in the pharmaceutical industry. His work has garnered attention for its potential to improve patient outcomes in managing chronic diseases.
Collaborations
He has collaborated with notable colleagues, including Naoki Kojima and Richard J Roman, to further advance his research and development efforts.
Conclusion
Hideki Tomoike's contributions to the medical field through his innovative patent highlight the importance of combining existing treatments to enhance therapeutic efficacy. His work represents a significant step forward in addressing the challenges of hypertension and diabetes management.